Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03027466 · ClinicalTrials.gov registry record · NA
Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging
A NA study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- NA
- Development phase
- 7,899
- Enrollment target
NCT03027466: Completed NA study, sponsored by National Cancer Institute (NCI).
NCT03027466 is a NA study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 7,899 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (463% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03027466, a NA study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 7,899 participants
- Enrollment target
Study Summary
Background: Quitting smoking is hard. It is easy to relapse. Smokers may think of temptation to smoke as a threat if they think it suggests that they are unable to meet the challenges of stopping. When people feel such a threat to their sense of self-identity, they may get defensive. They may want to downplay the importance of quitting. This could make them try to quit less. Self-affirmation is a process of focusing on strengths and values. This can offset threats to the self and promote healthier behavior. Objective: To explore people s values, smoking attitudes, and smoking behavior. Eligibility: People ages 18 and older who smoke Design: The study takes place entirely on a mobile device. Participants will give their age, gender, data about their smoking habits, and desired quit date. Then they will get different texts about quitting. Participants will answer follow-up surveys 1 and 3 months later. ...
Primary Outcome
Participants were asked to report the number of times they attempted to quit smoking at 1 month and 3 months.
Interventions
- BEHAVIORAL Self-affirmation induction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,899 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2019-09-01 |
| Phase | NA |
What the finished NCT03027466 record still lists
NCT03027466 is an interventional study that assigns participants to a tested intervention. Its 7,899 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (463% higher).
The record links to 0 conditions, and to 1 intervention - of which Self-affirmation induction is the first listed.
NCT03027466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03027466 about?
NCT03027466 is a clinical study titled "Integrating Use of Self-Affirmation Content Into a Mobile App to Promote Quit Attempts With Text-Based Smoking Cessation Intervention Messaging". Background: Quitting smoking is hard. It is easy to relapse. Smokers may think of temptation to smoke as a threat if they think it suggests that they are unable to meet the challenges of stopping. When people feel such a threat to their sense of self-identity, they may get defensive. They may want ...
What is the current status of trial NCT03027466?
This trial is currently completed. It is a NA study. The enrollment target is 7,899 participants. The study started on 2018-03-06. Estimated completion is 2019-09-01.
What interventions are being tested in trial NCT03027466?
The interventions under investigation include: Self-affirmation induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT03027466?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03027466's enrollment target sits among peer trials
7,899 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI